Peptide Solubility

Solubility is the concentration at which a peptide stops going into solution and starts staying as solid or aggregate. Two properties dominate it. The first is charge: molecules that repel each other stay apart, so solubility is highest where net charge is large and falls to a minimum at the isoelectric point where net charge is zero. The second is hydrophobic content. A sequence dense in leucine, isoleucine, valine, phenylalanine and tryptophan buries poorly in water, and long uninterrupted hydrophobic stretches are worse than the same residues scattered.

This yields a rule of thumb chemists use daily. A basic peptide, with a surplus of lysine and arginine, dissolves readily in slightly acidic water; an acidic peptide, rich in aspartate and glutamate, prefers a mildly basic buffer; and a peptide with both, or with a strongly hydrophobic core, may need to be dissolved in a small volume of an organic co-solvent before dilution into aqueous buffer. Salt form matters too, since a trifluoroacetate salt and an acetate salt of the same sequence do not necessarily behave alike.

Solubility sets a hard ceiling on formulation. A concentrated subcutaneous product has to hold its dose in well under a millilitre, so a peptide that saturates at low concentration cannot be delivered that way without reformulation, a different salt, or sequence changes. This is a common reason a compound that works in a laboratory buffer never becomes a practical injectable.

The trap is confusing dissolved with stable. A peptide can be driven into solution at a concentration it will not hold, and then slowly aggregate, adsorb to the container wall, or precipitate on cooling. Solutions near the solubility limit are also the ones most sensitive to a pH shift or a temperature change, which is why a clear vial at reconstitution says nothing about the same vial days later.